McAdam LLC’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$310K Buy
618
+34
+6% +$16.3K 0.01% 376
2026
Q1
$287K Buy
584
+123
+27% +$66.8K 0.01% 355
2025
Q4
$267K Buy
+461
New +$261K 0.01% 346
2025
Q1
Sell
-448
Closed -$233K 386
2024
Q4
$233K Buy
448
+16
+4% +$8.8K 0.01% 321
2024
Q3
$267K Buy
432
+15
+4% +$8.88K 0.02% 279
2024
Q2
$231K Buy
+417
New +$239K 0.01% 282
2024
Q1
Sell
-395
Closed -$210K 313
2023
Q4
$210K Buy
+395
New +$191K 0.02% 262
2018
Q2
Sell
-16
Closed -$3K 803
2018
Q1
$3K Buy
+16
New +$3.36K ﹤0.01% 489

Other funds holding TMO

McAdam LLC's TMO Position: Q2 2026 in Review

McAdam LLC increased its Thermo Fisher Scientific (TMO) stake by 5.8% in Q2 2026, buying an estimated $16.3K and bringing the position to 618 shares worth $310K. The position accounts for 0.01% of the portfolio, ranked #376.

McAdam LLC first reported a position in TMO in Q1 2018 and has held it in 8 quarters since. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • McAdam LLC held 618 shares of Thermo Fisher Scientific worth $310K as of Q2 2026.
  • McAdam LLC bought 34 Thermo Fisher Scientific shares in Q2 2026, an estimated $16.3K.
  • Thermo Fisher Scientific made up 0.01% of McAdam LLC's portfolio in Q2 2026, its #376 holding.
  • McAdam LLC first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 8 quarters since.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on McAdam LLC's 13F filing for Q2 2026, filed 4 Aug 2026.